Estimation of the bath Ankylosing Spondylitis Disease activity index cutoff for perceived symptom relief in patients with spondyloarthropathies

Journal of Rheumatology

Volumn 33, Issue 1, 2006, Pages 79-81

  Cohen, Jean David ^a,b   Cunin, Patrick ^a,c   Farrenq, Valérie ^a,b   Oniankitan, Owanoyo ^a,b   Carton, Laurence ^a,b   Chevalier, Xavier ^a,b   Claudepierre, Pascal ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b Department of Rheumatology ^*

^c Clinical Research Unit

Author keywords

Ankylosing spondylitis; Bath ankylosing spondylitis disease activity index; Cutoff; Patient assessment; Spondyloarthropathy

Indexed keywords

ANKYLOSING SPONDYLITIS; ASSAY; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CONTROL; FEMALE; FRANCE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SPONDYLOARTHROPATHY;

ANTIRHEUMATIC AGENTS; ENDPOINT DETERMINATION; EXPERT TESTIMONY; FEMALE; HUMANS; MALE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; ROC CURVE; SELF-EXAMINATION; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 30144445530     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Calin A. The individual with ankylosing spondylitis: defining disease status and the impact of the illness. Br J Rheumatol 1995;34:663-72.
2. Garrett S, Jenkison T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
3. Claudepierre P, Sibilia J, Goupille P, et al. Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol 1997;24:1954-8.
4. Waldner A, Cronstedt H, Stenstrom CH. The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity. Scand J Rheumatol 1999;111 Suppl:10-6.
5. Brandt J, Westhoff G, Rudwaleit M, et al. Adaptation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany. Z Rheumatol 2003;62:264-73.
6. Cardiel MH, Londono JD, Gutierrez E, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 2003;21:451-8.
7. Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology Oxford 2004;43:1565-8.
8. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005;25:280-4.
9. Braun J, Pham T, Sieper J, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
10. Gladman DD. Established criteria for disease controlling drugs in ankylosing spondylitis. Ann Rheum Dis 2003;62:793-4.
11. Oniankitan O, Ranaivo N, Carton L, Chevalier X, Claudepierre P. Poorly and well controlled spondyloarthropathies: a comparison of 2 groups of patients. J Rheumatol 2005;32:77-9.
12. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
13. Taylor AL, Balakrishnan C, Calin A. Reference centile charts for measures of disease activity, functional impairment and metrology in ankylosing spondylitis. Arthritis Rheum 1998;41:1119-25.
14. Pavy S, Brophy S, Calin A. Establishment of the minimum clinically important difference for the Bath Ankylosing Spondylitis Indices: a prospective study. J Rheumatol 2005;32:80-5.
15. Taylor WJ, Harrison AA. Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum 2004;51:311-5.
16. Claudepierre P, Sibilia J, Roudot-Thoraval F, et al. Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol 1998;25:1927-31.